CytomX Patent Rights. Schedule 1.159 is incorporated herein as are the following patent rights: Title CYTX Ref No. CY Serial No. / Issue No. Filing / Issue Dates Priority Dates Status Assignee Pub No. Pub Date [***]† † Two pages of text have been omitted. ***Certain information contained herein has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 1 contract
Samples: Option and License Agreement (CytomX Therapeutics, Inc.)
CytomX Patent Rights. Schedule 1.159 is incorporated herein as are the following patent rights: Title CYTX Ref No. CY Serial No. / Issue No. Filing / Issue Dates Priority Dates Status Assignee Pub No. Pub Date [***]† † Two pages of text have been omitted. **** Certain information contained herein has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 1 contract
Samples: Option and License Agreement (CytomX Therapeutics, Inc.)
CytomX Patent Rights. Schedule 1.159 is incorporated herein as are the following patent rights: Title CYTX Ref No. CY Serial No. / Issue No. Filing / Issue Dates Priority Dates Status Assignee Pub No. Pub Date [***]† † Two pages of text have been omitted. ***Certain information contained herein has been omitted and filed separately with the Securities and Exchange Commissionpursuant to Regulation S-K 601(b)(10). Confidential treatment has been requested granted with respect to the omitted portions.. Schedule 8.2.8
Appears in 1 contract
Samples: Option and License Agreement (CytomX Therapeutics, Inc.)
CytomX Patent Rights. Schedule 1.159 is incorporated herein as are the following patent rights: Title CYTX Ref No. CY Serial No. / Issue No. Filing / Issue Dates Priority Dates Status Assignee Pub No. Pub Date [***]† † Two †Two pages of text have been omitted. ***Certain information contained herein has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 1 contract
Samples: Option and License Agreement (CytomX Therapeutics, Inc.)